Given the significant alterations in the JAK-STAT pathway observed in our GSEA analysis, and considering that activation of JAK1 and JAK2 inhibits tumour cell susceptibility to NK cells by upregulating PD-L1 expression 39, we examined changes in the JAK-STAT signalling pathway in RBM10 knockdown cell lines. The gene discussed is JAK1; the disease is neoplasm.